Browse by Title

Type here to filter the list

H
Harnessing Real-world Evidence to Address Drug Shortages (SW-4A)
Favorite

Adel Alrwisan – Saudi Food and Drug Authority ### 2641675###Presenting Author######Saudi Food and Drug Authority###
Presenting Author: Adel Alrwisan – Saudi Food and Drug Authority
### @@@ Grace Chai – United States Food and Drug Administration ### 2644082### Co-Author######United States Food and Drug Administration###
Co-Author: Grace Chai – United States Food and Drug Administration
### @@@ Mina Tadrous, PhD – University of Toronto ### 2642072### Co-Author######University of Toronto###
Co-Author: Mina Tadrous, PhD – University of Toronto
### @@@ Tom Kraus ### 2770780###Co-Author#########
Co-Author: Tom Kraus
### @@@ Hisham Aljadhey ### 2770781###Co-Author#########
Co-Author: Hisham Aljadhey
### SW-4A
Heterogeneity of treatment effects for GLP1-RA on kidney outcomes in patients with type 2 diabetes mellitus (6E-06)
Favorite

Yang Xu – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China ### 2641872###Presenting Author######Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China###
Presenting Author: Yang Xu – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
### @@@ Tao Huang – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China ### 2642388###Co-Author######Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China###
Co-Author: Tao Huang – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
### @@@ Ruyu Li – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China ### 2642389###Co-Author######Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China###
Co-Author: Ruyu Li – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
### @@@ Zhuoheng Shen – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China ### 2642390###Co-Author######Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China###
Co-Author: Zhuoheng Shen – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
### @@@ Edouard L. Fu – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands ### 2642391###Co-Author######Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands###
Co-Author: Edouard L. Fu – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
### @@@ Juan-Jesus Carrero – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden ### 2642392###Co-Author######Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden###
Co-Author: Juan-Jesus Carrero – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
### 6E-06
Heterogeneous Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Acute Kidney Injury: A Causal Learning Approach (6E-02)
Favorite

Serena Jingchuan Guo – UNIVERSITY OF FLORIDA ### 2641901###Presenting Author######UNIVERSITY OF FLORIDA###
Presenting Author: Serena Jingchuan Guo – UNIVERSITY OF FLORIDA
### @@@ Yao An Li – UNIVERSITY OF FLORIDA ### 2641902###Co-Author######UNIVERSITY OF FLORIDA###
Co-Author: Yao An Li – UNIVERSITY OF FLORIDA
### @@@ Jiang Bian – Indiana University ### 2641904###Co-Author######Indiana University###
Co-Author: Jiang Bian – Indiana University
### 6E-02
High-value Outcomes (4D)
Favorite

Kimberly G. Brodovicz, DrPH – Boerhinger Ingelheim ### 1360212###Co-Moderator###Exec Dir, Group Head Inflammation, Global Epi & RWE###Boerhinger Ingelheim###
Co-Moderator: Kimberly G. Brodovicz, DrPH – Boerhinger Ingelheim
### @@@ Benjamin Bates, MD – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 2644360###Co-Moderator######Rutgers Center for Pharmacoepidemiology and Treatment Science###
Co-Moderator: Benjamin Bates, MD – Rutgers Center for Pharmacoepidemiology and Treatment Science
### 4D
How should we interpret self-controlled study designs in the era of causal inference? (SW-3C)
Favorite

Kenneth Man – School of Pharmacy, University College London ### 2641532###Presenting Author###Lecturer###School of Pharmacy, University College London###
Presenting Author: Kenneth Man – School of Pharmacy, University College London
### @@@ Siu Chung Andrew Yuen – School of Pharmacy, University College London ### 2641588###Presenting Author######School of Pharmacy, University College London###
Presenting Author: Siu Chung Andrew Yuen – School of Pharmacy, University College London
### @@@ Cindy Zhou – Moderna, Inc. ### 2641589###Co-Author######Moderna, Inc.###
Co-Author: Cindy Zhou – Moderna, Inc.
### @@@ Sudha Raman – Duke University ### 2641590###Co-Author######Duke University###
Co-Author: Sudha Raman – Duke University
### @@@ Edward Chia-Cheng Lai, PhD – Population Health Data Center, National Cheng Kung University ### 2641536###Presenting Author######Population Health Data Center, National Cheng Kung University###
Presenting Author: Edward Chia-Cheng Lai, PhD – Population Health Data Center, National Cheng Kung University
### @@@ Ju-Young Shin, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 2641592###Presenting Author######School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Presenting Author: Ju-Young Shin, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Anna Schultze – London School of Hygiene and Tropical Medicine ### 2641681###Presenting Author######London School of Hygiene and Tropical Medicine###
Presenting Author: Anna Schultze – London School of Hygiene and Tropical Medicine
### SW-3C
How to design a pharmacoepidemiologic study of biologics including biosimilars and cell & gene therapies (SC-26)
Favorite

Jaclyn L. Bosco, PhD, MPH. FISPE (she/her/hers) – IQVIA ### 1046829###Presenting Author###Vice President and Global Head of Epidemiology & Database Studies###IQVIA###
Presenting Author: Jaclyn L. Bosco, PhD, MPH. FISPE (she/her/hers) – IQVIA
### she/her/hers @@@ Ylenia Ingrasciotta – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2642649###Presenting Author######Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Presenting Author: Ylenia Ingrasciotta – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Quazi Ataher – CSL Behring LLC ### 2642628###Presenting Author###Head Clinical Epidemiology###CSL Behring LLC###
Presenting Author: Quazi Ataher – CSL Behring LLC
### SC-26